Cargando…
Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
We investigated the diagnostic and prognostic potential of serum N-glycan profiling for castration-resistant prostate cancer (CRPC). We retrospectively investigated serum N-glycan structural analysis by glycoblotting for 287 patients with benign prostatic hyperplasia (BPH), 289 patients with newly d...
Autores principales: | Matsumoto, Teppei, Hatakeyama, Shingo, Yoneyama, Tohru, Tobisawa, Yuki, Ishibashi, Yusuke, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ito, Hiroyuki, Nishimura, Shin-Ichiro, Ohyama, Chikara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856113/ https://www.ncbi.nlm.nih.gov/pubmed/31727974 http://dx.doi.org/10.1038/s41598-019-53384-y |
Ejemplares similares
-
Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021) -
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020) -
Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014) -
Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016) -
Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)